Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer. Academic Article uri icon

Overview

publication date

  • February 1, 1980

Research

keywords

  • Aminoacridines
  • Antineoplastic Agents
  • Carcinoma
  • Lung Neoplasms

Identity

Scopus Document Identifier

  • 0019222609

PubMed ID

  • 6893294

Additional Document Info

volume

  • 64

issue

  • 2-3